Biolife Solutions Inc Revenue Growth Rates (BLFS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Biolife Solutions Inc   (NASDAQ: BLFS)
 

BLFS's Revenue Growth by Quarter and Year

Biolife Solutions Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLFS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 28.47
1st Quarter March 27.50
FY 55.97

BLFSs Annual Revenue
Biolife Solutions Inc 's Revenue in the fiscal year 2025 $ 96.12 millions
Biolife Solutions Inc 's Revenue in the fiscal year 2024 $ 82.25 millions
Biolife Solutions Inc 's Revenue in the fiscal year 2023 $ 143.27 millions
Biolife Solutions Inc 's Revenue in the fiscal year 2022 $ 161.76 millions
Biolife Solutions Inc 's Revenue in the fiscal year 2021 $ 119.16 millions




BLFS Revenue second quarter 2026 Y/Y Growth Comment
Biolife Solutions Inc reported Revenue increase of 11.98% year on year in the second quarter 2026, to $ 28.47 millions, this is lower than Biolife Solutions Inc 's recent average Revenue rise of 42.62%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 84 other companies have achieved higher Revenue growth. While Biolife Solutions Inc ' s Revenue growth of 11.98% ranks overall at the positon no. 1515 in the second quarter 2026.


BLFS Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - - - -26.05 %
3rd Quarter September - -8.18 % -8.28 % -18.21 %
2nd Quarter June 11.98 % -10.27 % -28.3 % -2.52 %
1st Quarter March 14.87 % -24.55 % -15.84 % 4.09 %
FY   - 10.22 % -39.13 % -

Financial Statements
Biolife Solutions Inc 's second quarter 2026 Revenue $ 28.47 millions BLFS's Income Statement
Biolife Solutions Inc 's second quarter 2025 Revenue $ 25.42 millions Quarterly BLFS's Income Statement


BLFS Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - -33.42 % - -1.8 %
3rd Quarter September - 10.42 % 7.91 % -15.64 %
2nd Quarter June 3.51 % 6.18 % -10.72 % 4.8 %
1st Quarter March 47.14 % - -3.06 % -14.82 %
FY (Year on Year)   - 10.22 % -39.13 % -


Back to BLFS Growth rate Comparisons >> Back to BLFS Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #85
Healthcare Sector #254
Overall #1515

Revenue Y/Y Growth Statistics
High Average Low
214.56 % 42.62 % -62.54 %
(Mar 31 2022)   (Mar 31 2015)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #85
Healthcare Sector #254
Overall #1515
Revenue Y/Y Growth Statistics
High Average Low
214.56 % 42.62 % -62.54 %
(Mar 31 2022)   (Mar 31 2015)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Biolife Solutions Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
105.45 % 9.85 % -53.69 %
(Dec 31 2013)  


BLFS's II. Quarter Q/Q Revenue Comment
Biolife Solutions Inc achieved in the II. Quarter 2026 below company average Revenue growth of 3.51% quarter on quarter, to $ 28.47 millions.

Within Medical Equipment & Supplies industry 53 other companies have achieved higher Revenue quarter on quarter growth. While Biolife Solutions Inc 's Revenue growth quarter on quarter, overall rank is 1293.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #54
Healthcare Sector #185
Overall #1293
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #54
Healthcare Sector #185
Overall #1293
Revenue Q/Q Growth Statistics
High Average Low
105.45 % 9.85 % -53.69 %
(Dec 31 2013)  


BLFS's II. Quarter Q/Q Revenue Comment
Biolife Solutions Inc achieved in the II. Quarter 2026 below company average Revenue growth of 3.51% quarter on quarter, to $ 28.47 millions.

Within Medical Equipment & Supplies industry 53 other companies have achieved higher Revenue quarter on quarter growth. While Biolife Solutions Inc 's Revenue growth quarter on quarter, overall rank is 1293.


Biolife Solutions Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 102.72 $ 99.67 $ 96.12 $ 74.01 $ 76.51
Y / Y Revenue Growth (TTM) 34.26 % 25.51 % 10.22 % -40.01 % -39.33 %
Year on Year Revenue Growth Overall Ranking # 3530 # 0 # 0 # 2324 # 1847
Seqeuential Revenue Change (TTM) 3.05 % 3.7 % 29.88 % -3.27 % -3.66 %
Seq. Revenue Growth (TTM) Overall Ranking # 2882 # 1975 # 0 # 2398 # 1665


Cumulative Revenue growth Comment
Although Biolife Solutions Inc 's Annual Revenue growth year on year were below company's average 39.07% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 34.26% year on year, from 25.51% in Mar 31 2026.

In the Healthcare sector 485 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3530.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 148
Healthcare Sector # 486
Overall # 3530

Revenue TTM Y/Y Growth Statistics
High Average Low
162.5 %
 39.07 %
-48.97 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 148
Sector # 410
S&P 500 # 2882
Cumulative Revenue growth Comment
Although Biolife Solutions Inc 's Annual Revenue growth year on year were below company's average 39.07% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 34.26% year on year, from 25.51% in Mar 31 2026.

In the Healthcare sector 485 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3530.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 148
Healthcare Sector # 486
Overall # 3530

Revenue TTM Y/Y Growth Statistics
High Average Low
162.5 %
39.07 %
-48.97 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 148
Sector # 410
S&P 500 # 2882




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BLFS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Transmedics Group Inc 20.70%$ 20.702 millions
Irhythm Holdings Inc 20.62%$ 20.615 millions
Delcath Systems Inc 20.60%$ 20.604 millions
Castle Biosciences Inc 20.14%$ 20.140 millions
Procept Biorobotics Corporation20.00%$ 20.004 millions
Biomarin Pharmaceutical Inc19.91%$ 19.905 millions
Cannapharmarx Inc 19.26%$ 19.261 millions
Anika Therapeutics Inc 19.18%$ 19.176 millions
Bioaffinity Technologies Inc 18.99%$ 18.992 millions
Aurinia Pharmaceuticals Inc 18.87%$ 18.872 millions
Camp4 Therapeutics Corporation18.84%$ 18.838 millions
Lensar Inc 18.37%$ 18.371 millions
Immunocore Holdings Plc18.34%$ 18.336 millions
Innovage Holding Corp 18.31%$ 18.307 millions
Koru Medical Systems Inc 18.15%$ 18.153 millions
Clearpoint Neuro Inc 18.07%$ 18.068 millions
Avita Medical Inc 17.83%$ 17.830 millions
Xencor Inc17.46%$ 17.458 millions
Logicmark Inc17.39%$ 17.387 millions
Ensign Group Inc17.33%$ 17.325 millions
Medpace Holdings Inc 17.24%$ 17.242 millions
Geron Corporation17.22%$ 17.220 millions
Si bone inc 17.16%$ 17.159 millions
Cvrx inc 16.77%$ 16.766 millions
Regeneron Pharmaceuticals Inc 16.73%$ 16.735 millions
Invo Fertility Inc 16.73%$ 16.732 millions
Pro dex Inc 16.65%$ 16.646 millions
Royalty Pharma Plc16.50%$ 16.499 millions
Acadia Pharmaceuticals Inc 16.40%$ 16.402 millions
Harvard Bioscience Inc 16.35%$ 16.352 millions


About Biolife Solutions Inc Revenue Growth Rates (BLFS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Biolife Solutions Inc (CIK 834365).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-054355
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Biolife Solutions Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.